Targeting Spike Glycans to Inhibit SARS-CoV2 Viral Entry

Mostrar otras versiones (1)

SARS-CoV-2 Spike harbors glycans which function as ligands for lectins. Therefore, it should be possible to exploit lectins to target SARS-CoV-2 and inhibit cellular entry by binding glycans on the Spike protein. Burkholderia oklahomensis agglutinin (BOA) is an antiviral lectin that interacts with v...

Descripción completa

Detalles Bibliográficos
Autores principales: Guseman, Alex J., Rennick, Linda J., Nambulli, Sham, Roy, Chandra N., Martinez, David R., Yang, Darian T., Bhinderwhala, Fatema, Vergara, Sandra, Baric, Ralph S., Ambrose, Zandrea, Duprex, W. Paul, Gronenborn, Angela M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cold Spring Harbor Laboratory 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9810211/
https://www.ncbi.nlm.nih.gov/pubmed/36597530
http://dx.doi.org/10.1101/2022.12.22.521642

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9810211/
https://www.ncbi.nlm.nih.gov/pubmed/36597530
http://dx.doi.org/10.1101/2022.12.22.521642

Ejemplares similares